Gamma-aminobutyric acid (GABA)

Alternative Medicine Review

Volumn 12, Issue 3, 2007, Pages 274-279

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPRAZOLAM; BACLOFEN; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; FLURAZEPAM; GABAPENTIN; GLUTAMIC ACID; KEMSTRO; NEUROTRANSMITTER; PHARMAGABA; PHENOBARBITAL; PHOSPHATIDYLSERINE; QUAZEPAM; TEMAZEPAM; TIAGABINE; TRIAZOLAM; UNCLASSIFIED DRUG; VALERIAN; VALERIC ACID; VALPROIC ACID; VIGABATRIN; ZOLPIDEM TARTRATE;

ACROPHOBIA; ALPHA RHYTHM; ANXIETY; ARTICLE; BETA RHYTHM; BIOCHEMISTRY; CENTRAL NERVOUS SYSTEM; DEPRESSION; DIET SUPPLEMENTATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; ELECTROENCEPHALOGRAM; EPILEPSY; EXTRACELLULAR FLUID; GILLES DE LA TOURETTE SYNDROME; HUMAN; LACTOBACILLUS; MOTOR DYSFUNCTION; NEUROLOGY; NONHUMAN; PANCREAS ISLET CELL; PANIC; PARKINSON DISEASE; PHOBIA; SEIZURE; SINGLE DRUG DOSE; SLEEP DISORDER; STRESS; TARDIVE DYSKINESIA; UNITED STATES;

ANXIETY; DEPRESSION; EPILEPSY; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPNOTICS AND SEDATIVES; MOVEMENT DISORDERS; STRESS;

EID: 35348983431     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Smith TA. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. Br J Biomed Sci 2001;58:111-121.
2. Cavagnini F, Pinto M, Dubini A, et al. Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man. Metabolism 1982;31:73-77.
3. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 2003;37:133-146.
4. Kendell SF, Krystal JH, Sanacora G. GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opin Ther Targets 2005;9:153-168.
5. Kugaya A, Sanacora G. Beyond monoamines: glutamatergic function in mood disorders. CNS Spectr 2005;10:808-819.
6. Krystal JH, Sanacora G, Blumberg H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 2002;7:S71-S80.
7. Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia 2001;42:8-12.
8. Gottesmann C. GABA mechanisms and sleep. Neuroscience 2002;111:231-239.
9. Levy LM, Henkin RI. Brain gamma-aminobutyric acid levels are decreased in patients with phantageusia and phantosmia demonstrated by magnetic resonance spectroscopy. J Comput Assist Tomogr 2004;28:721-727.
10. Nutt D. GABAA receptors: subtypes, regional distribution, and function. J Clin Sleep Med 2006;2:S7-S11.
11. Spila B, Szumillo A. Gabapentin (GBP) in panic disorders - case report. Psychiatr Pol 2006;40:1061-1068. [Article in Polish]
12. Streeter CC, Jensen JE, Perlmutter RM, et al. Yoga asana sessions increase brain GABA levels: a pilot study. J Altern Complement Med 2007;13:419-426.
13. Khom S, Baburin I, Timin E, et al. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology 2007;53:178-187.
14. Unpublished data provided by Pharma Foods International LTD., Kyoto, Japan.
15. Abdou AM, Higashiguchi S, Horie K, et al. Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. Biofactors 2006;26:201-208.
16. Green ML, Green RG, Santoro W. Daily relaxation modifies serum and salivary immunoglobulins and psychophysiologic symptom severity. Biofeedback Self Regul 1988;13:187-199.
17. Shiah IS, Yatham LN. GABA function in mood disorders: an update and critical review. Life Sci 1998;63:1289-1303.
18. Brambilla P, Perez J, Barale F, et al. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:715,721-737.
19. Epperson CN, Gueorguieva R, Czarkowski KA, et al. Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study. Psychopharmacology (Berl) 2006;186:425-433.
20. Bhagwagar Z, Wylezinska M, Jezzard P, et al. Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 2007;Jul 11:1-6. [Epub ahead of print]
21. Orser BA, Extrasynaptic GABAA receptors are critical targets for sedative-hypnotic drugs. J Clin Sleep Med 2006;2:S12-S18.
22. Palagini L, Campbell IG, Tan X, et al. Independence of sleep EEG responses to GABAergic hypnotics: biological implications. J Psychiatr Res 2000;34:293-300.
23. Roth T, Soubrane C, Titeux L, et al. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med 2006;7:397-406.
24. Bazil CW, Battista J, Basner RC. Gabapentin improves sleep in the presence of alcohol. J Clin Sleep Med 2005;1:284-287.
25. Landmark CJ. Targets for antiepileptic drugs in the synapse. Med Sci Monit 2007;13:RA1-7.
26. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 2005;5:3-14.
27. Yudkoff M, Daikhin Y, Nissim I, et al. Ketogenic diet, brain glutamate metabolism and seizure control. Prostaglandins Leukot Essent Fatty Acids 2004;70:277-285.
28. Cantello R, Varrasi C, Tarletti R, et al. Ketogenic diet: electrophysiological effects on the normal human cortex. Epilepsia 2007;June 11. [Epub ahead of print]
29. Loeb C, Benassi E, Bo GP, et al. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Res 1987;1:209-212.
30. Cocito L, Bianchetti A, Bossi L, et al. GABA and phosphatidylserine in human photosensitivity: a pilot study. Epilepsy Research 1994;17:49-53.
31. Toffano G, Mazzari S, Zanotti A, Bruni A. Synergistic effect of phosphatidylserine with gamma-aminobutyric acid in antagonizing the isoniazid-induced convulsions in mice. Neurochem Res 1984;9:1065-1073.
32. Loeb C, Benassi E, Besio G, et al. Liposome-entrapped GABA modifies behavioral and electrographic changes of penicillin-induced epileptic activity. Neurology 1982;32:1234-1238.
33. Loeb C, Bo GP, Scotto PA, et al. GABA and phospholipids in penicillin-induced seizures. Exp Neurol 1985;90:278-280.
34. Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001;56:599-604.
35. Awaad Y. Tics in Tourette syndrome: new treatment options. J Child Neurol 1999;14:316-319.
36. Chen L, Xie JX, Fung KS, Yung WH. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus. Neurosci Res 2007;58:77-85.
37. Abe K, Hikita T, Sakoda S. A hypnotic drug for sleep disturbances in patients with Parkinson's disease. No To Shinkei 2005;57:301-305. [Article in Japanese]
38. Van Blercom N, Lasa A, Verger K, et al. Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease. Clin Neuropharmacol 2004;27:124-128.
39. Stahl SM, Thornton JE, Simpson ML, et al. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders. Biol Psychiatry 1985;20:888-893.
40. Kakee A, Takanaga H, Terasaki T, et al. Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier. J Neurochem 2001;79:110-118.